FDA Approves The Effectiveness Of The Use Of The Patented 830Laser Treatment On Carpal Tunnel Syndrome! - GM Study, Anderson et. al. (1995)

Carpal Tunnel Syndrome is a serious ailment that affects the quality of life for millions of people each year. Medical science has searched diligently for affordable, non-surgical carpal tunnel treatment modalities. But until the 830Laser was approved as a safe and effective carpal tunnel treatment, few options were available.

General Motors (GM) conducted a 7-month, double-blind study to determine the effectiveness of low level laser therapy in treating Carpal Tunnel Syndrome, (CTS) as well as a seven-year study on its use in managing other types of chronic pain. The FDA recently approved the therapy, which may be effective in reducing the tissue inflammation that causes the symptoms of CTS. Involved in the study were several medical practitioners from General Motors as well as Baylor University.

General Motors CTS Study
General Motors, in 1995 had spent a total of $2 billion on the treatment of Worker’s Compensation claims related to Carpal Tunnel Syndrome. They conducted a study of 119 patients randomly assigned to two groups, one receiving physical therapy coupled with low level laser light therapy (LLLT) using the 830Laser, the other half received physical therapy along with a placebo laser treatment.

Results
* Return to work following treatment was 75% higher for the active laser treated group (72% vs. 41%)
* Pinch and grip strength was significantly higher in the active laser treated group.
* Range of motion improved significantly greater for the active laser treated group. Overall conclusion is that using the 830laser for carpal tunnel treatment combined with physical therapy improves functional measures of wrist-hand work performance and results in greater probability of return to work than physical therapy alone.